A protein found in brown fat, but not typical white fat, is key to how the energy-burning brown fat cells function
While most fat cells in the human body store energy, everyone has a small subset of brown fat cells that do the opposite—burn energy and generate heat. Now, Salk researchers have discovered how the molecule ERR? gives this “healthier” brown fat its energy-expending identity, making those cells ready to warm you up when you step into the cold, and potentially offering a new therapeutic target for diseases related to obesity. The paper appears in Cell Reports on March 13, 2018.
“This not only advances our understanding of how the body responds to cold, but could lead to new ways to control the amount of brown fat in the body, which has links to obesity, diabetes and fatty liver disease,” says senior author Ronald Evans, Howard Hughes Medical Institute investigator and holder of Salk’s March of Dimes Chair in Molecular and Developmental Biology.
Until about a decade ago, scientists thought that only babies—who can’t yet shiver to warm up—had brown fat in their bodies. Studies have since shown that adults also have brown fat, albeit at much lower levels, and people with lower body mass indexes (BMIs) tend to have more of it. At a cellular level, brown fat cells are crammed full of energy-generating mitochondria, which give the cells their brown color.
In the new work, Evans’ group focused on estrogen-related receptor gamma (ERR?), a gene that is active at high levels in brown fat cells.
“We were interested in what maintains brown fat, even when we’re not exposed to cold all the time,” says Maryam Ahmadian, a Salk research associate and first author of the new paper.
The team found that brown fat cells express the ERR? gene all the time (not just in response to cold) and that white fat cells do not express the gene at all. And by studying mice lacking the gene for ERR? (and therefore unable to make the ERRy molecule), the team observed that all brown fat cells resembled white cells in these mice. Additionally, the animals were unable to maintain their body temperature when exposed to cold temperatures. While 80 percent of normal mice are able to handle a temperature drop, all mice lacking ERR? did not tolerate the cold. However, there was no difference in the metabolism or weight of the mice. Together, the experiments reveal that ERR? is key to helping brown fat maintain its identity and its ability to respond to cold.
Since the ERR? gene codes for a protein that can travel into the cell nucleus and directly control the expression of other genes, the team also probed which genes were mediated by ERR? in brown fat cells. They pinpointed a number of genes already known to be important in brown fat, but which hadn’t been specifically linked to ERR? inthe past.
“We uncovered the factors that are both involved in protection against the cold and underpin brown fat identity,” says Michael Downes, a Salk senior scientist and co–senior author of the paper.
The group is planning future studies that look at the effect of activating ERR? in white fat cells—which they suspect could make some white fat resemble brown fat, and potentially help treat obesity and diabetes. They also want to study whether the role of ERR? in the brown fat of humans is the same as what they’ve observed in mice.
Learn more: Molecule that gives energy-burning brown fat its identity could lead to drugs for obesity
The Latest on: Drug for obesity
[google_news title=”” keyword=”drug for obesity” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug for obesity
- Ozempic changed the lives of obesity patients. And then we had to stop prescribing iton April 26, 2024 at 11:03 pm
Predictably, the result of this communication has been calamitous for patients: many of those returning to our obesity clinic in Galway in the past year have lost all of the health gains they made, ...
- Health 360: Experts on obesity drugs, quick fix solutions for weight losson April 26, 2024 at 10:19 pm
In this episode of Health 360, experts share insights on the health risks associated with obesity and how there is an industry dedicated to quick fix solutions for weight loss.
- Sen. Sanders investigates high cost of obesity drugs Ozempic and Wegovyon April 26, 2024 at 5:30 pm
It comes as state officials and lawmakers weigh whether to expand Medicaid coverage that includes their prescription.
- This Popular Weight Loss Drug May Help People With Sleep Apnea, Study Findson April 26, 2024 at 7:34 am
Zepbound, by Eli Lilly, may improve sleep apnea symptoms in those with the condition. Sleep experts explain how the weight loss drug may reduce sleep apnea.
- Why the obesity drug market is about to get a lot more crowdedon April 26, 2024 at 6:15 am
The U.S. is set to see a surge in obesity drug introductions over the next five years. Here’s a rundown of the potential entrants.
- What do weight loss drugs mean for a diet industry built on eating less, exercise?on April 25, 2024 at 3:46 am
A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He's lost 30 pounds, and has started eating healthier food and exercising — the habits behind ...
- Given their side effects, weight-loss drugs might not be good for allon April 24, 2024 at 12:28 pm
When will we see through the haze of drugs like Ozempic and Wegovy? Hopefully soon. These drugs might reach 30 million U.S. users by 2030. Surging, off-label demand has come with unintentional ...
- 4 Reasons Weight Loss Drugs Aren't Working for Youon April 24, 2024 at 8:52 am
Sleeping poorly and being stressed out can also limit the body’s ability to lose weight. A lack of rest often leads to an imbalance in hunger hormones, which stimulates appetite and encourages fat ...
- Moving the conversation about obesity beyond the scaleon April 18, 2024 at 5:00 pm
The public discussion on obesity and weight loss, particularly concerning GLP-1 receptor agonists — the technical name for drugs like Wegovy (semaglutide) and Zepbound (tirzepatide ...
via Bing News